메뉴 건너뛰기




Volumn 198, Issue 4, 2017, Pages 1685-1695

A B cell epitope peptide derived from the major grass pollen allergen Phl p 1 boosts allergen-specific secondary antibody responses without allergen-specific T cell help

Author keywords

[No Author keywords available]

Indexed keywords

B CELL EPITOPE RECEPTOR; EPITOPE; HYBRID PROTEIN; IMMUNOGLOBULIN E ANTIBODY; PHL P 1 ALLERGEN; POLLEN ANTIGEN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; ALLERGEN; IMMUNOGLOBULIN E; PEPTIDE FRAGMENT; PHLPI PROTEIN, PHLEUM PRATENSE; PLANT PROTEIN;

EID: 85014721575     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501741     Document Type: Article
Times cited : (14)

References (50)
  • 1
    • 0033769924 scopus 로고    scopus 로고
    • What are the important allergens in grass pollen that are linked to human allergic disease?
    • Suphioglu, C. 2000. What are the important allergens in grass pollen that are linked to human allergic disease? Clin. Exp. Allergy 30: 1335-1341.
    • (2000) Clin. Exp. Allergy , vol.30 , pp. 1335-1341
    • Suphioglu, C.1
  • 2
    • 84886285872 scopus 로고    scopus 로고
    • Multiple grass mixes as opposed to single grasses for allergen immunotherapy in allergic rhinitis
    • Gangl, K., V. Niederberger, and R. Valenta. 2013. Multiple grass mixes as opposed to single grasses for allergen immunotherapy in allergic rhinitis. Clin. Exp. Allergy 43: 1202-1216.
    • (2013) Clin. Exp. Allergy , vol.43 , pp. 1202-1216
    • Gangl, K.1    Niederberger, V.2    Valenta, R.3
  • 3
    • 0023726312 scopus 로고
    • Epidemiology of emergency room asthma in northern California: Association with IgE antibody to ryegrass pollen
    • Pollart, S. M., M. J. Reid, J. A. Fling, M. D. Chapman, and T. A. Platts-Mills. 1988. Epidemiology of emergency room asthma in northern California: association with IgE antibody to ryegrass pollen. J. Allergy Clin. Immunol. 82: 224-230.
    • (1988) J. Allergy Clin. Immunol. , vol.82 , pp. 224-230
    • Pollart, S.M.1    Reid, M.J.2    Fling, J.A.3    Chapman, M.D.4    Platts-Mills, T.A.5
  • 6
    • 0013855374 scopus 로고
    • Isoallergens from rye grass pollen
    • Johnson, P., and D. G. Marsh. 1965. Isoallergens from rye grass pollen. Nature 206: 935-937.
    • (1965) Nature , vol.206 , pp. 935-937
    • Johnson, P.1    Marsh, D.G.2
  • 8
    • 0029999353 scopus 로고    scopus 로고
    • Common IgE-epitopes of recombinant Phl p I, the major timothy grass pollen allergen and natural group i grass pollen isoallergens
    • Laffer, S., M. Duchene, I. Reimitzer, M. Susani, C. Mannhalter, D. Kraft, and R. Valenta. 1996. Common IgE-epitopes of recombinant Phl p I, the major timothy grass pollen allergen and natural group I grass pollen isoallergens. Mol. Immunol. 33: 417-426.
    • (1996) Mol. Immunol. , vol.33 , pp. 417-426
    • Laffer, S.1    Duchene, M.2    Reimitzer, I.3    Susani, M.4    Mannhalter, C.5    Kraft, D.6    Valenta, R.7
  • 9
    • 0029559917 scopus 로고
    • T-cell epitopes of Phl p 1, major pollen allergen of timothy grass (Phleum pratense): Evidence for crossreacting and non-crossreacting T-cell epitopes within grass group i allergens
    • Schenk, S., H. Breiteneder, M. Susani, N. Najafian, S. Laffer, M. Duchêne, R. Valenta, G. Fischer, O. Scheiner, D. Kraft, et al. 1995. T-cell epitopes of Phl p 1, major pollen allergen of timothy grass (Phleum pratense): evidence for crossreacting and non-crossreacting T-cell epitopes within grass group I allergens. J. Allergy Clin. Immunol. 96: 986-996.
    • (1995) J. Allergy Clin. Immunol. , vol.96 , pp. 986-996
    • Schenk, S.1    Breiteneder, H.2    Susani, M.3    Najafian, N.4    Laffer, S.5    Duchêne, M.6    Valenta, R.7    Fischer, G.8    Scheiner, O.9    Kraft, D.10
  • 10
    • 0031924659 scopus 로고    scopus 로고
    • IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE
    • Niederberger, V., S. Laffer, R. Fröschl, D. Kraft, H. Rumpold, S. Kapiotis, R. Valenta, and S. Spitzauer. 1998. IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE. J. Allergy Clin. Immunol. 101: 258-264.
    • (1998) J. Allergy Clin. Immunol. , vol.101 , pp. 258-264
    • Niederberger, V.1    Laffer, S.2    Fröschl, R.3    Kraft, D.4    Rumpold, H.5    Kapiotis, S.6    Valenta, R.7    Spitzauer, S.8
  • 14
    • 0016441705 scopus 로고
    • Maximal rise in IgE antibody following ragweed pollination season
    • Henderson, L. L., J. B. Larson, and G. J. Gleich. 1975. Maximal rise in IgE antibody following ragweed pollination season. J. Allergy Clin. Immunol. 55: 10-15.
    • (1975) J. Allergy Clin. Immunol. , vol.55 , pp. 10-15
    • Henderson, L.L.1    Larson, J.B.2    Gleich, G.J.3
  • 17
    • 0043264799 scopus 로고    scopus 로고
    • Allergen-specific immunotherapy with a monophosphoryl lipid Aadjuvanted vaccine: Reduced seasonally boosted immunoglobulin e production and inhibition of basophil histamine release by therapy-induced blocking antibodies
    • Mothes, N., M. Heinzkill, K. J. Drachenberg, W. R. Sperr, M. T. Krauth, Y. Majlesi, H. Semper, P. Valent, V. Niederberger, D. Kraft, and R. Valenta. 2003. Allergen-specific immunotherapy with a monophosphoryl lipid Aadjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies. Clin. Exp. Allergy 33: 1198-1208.
    • (2003) Clin. Exp. Allergy , vol.33 , pp. 1198-1208
    • Mothes, N.1    Heinzkill, M.2    Drachenberg, K.J.3    Sperr, W.R.4    Krauth, M.T.5    Majlesi, Y.6    Semper, H.7    Valent, P.8    Niederberger, V.9    Kraft, D.10    Valenta, R.11
  • 20
    • 84956662881 scopus 로고    scopus 로고
    • IgE responses to exogenous and endogenous allergens in atopic dermatitis patients under long-term systemic cyclosporine A treatment
    • Lucae, S., P. Schmid-Grendelmeier, B. Wuthrich, D. Kraft, R. Valenta, and B. Linhart. 2016. IgE responses to exogenous and endogenous allergens in atopic dermatitis patients under long-term systemic cyclosporine A treatment. Allergy 71: 115-118.
    • (2016) Allergy , vol.71 , pp. 115-118
    • Lucae, S.1    Schmid-Grendelmeier, P.2    Wuthrich, B.3    Kraft, D.4    Valenta, R.5    Linhart, B.6
  • 21
    • 84902437071 scopus 로고    scopus 로고
    • Persistence of IgE-associated allergy and allergen-specific IgE despite CD4+ T cell loss in AIDS
    • Marth, K., E. Wollmann, D. Gallerano, P. Ndlovu, I. Makupe, R. Valenta, and E. Sibanda. 2014. Persistence of IgE-associated allergy and allergen-specific IgE despite CD4+ T cell loss in AIDS. PLoS One 9: e97893.
    • (2014) PLoS One , vol.9 , pp. e97893
    • Marth, K.1    Wollmann, E.2    Gallerano, D.3    Ndlovu, P.4    Makupe, I.5    Valenta, R.6    Sibanda, E.7
  • 22
    • 33947263596 scopus 로고    scopus 로고
    • Costimulation blockade inhibits allergic sensitization but does not affect established allergy in a murine model of grass pollen allergy
    • Linhart, B., S. Bigenzahn, A. Hartl, C. Lupinek, J. Thalhamer, R. Valenta, and T. Wekerle. 2007. Costimulation blockade inhibits allergic sensitization but does not affect established allergy in a murine model of grass pollen allergy. J. Immunol. 178: 3924-3931.
    • (2007) J. Immunol. , vol.178 , pp. 3924-3931
    • Linhart, B.1    Bigenzahn, S.2    Hartl, A.3    Lupinek, C.4    Thalhamer, J.5    Valenta, R.6    Wekerle, T.7
  • 25
    • 0035464780 scopus 로고    scopus 로고
    • Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination
    • Focke, M., V. Mahler, T. Ball, W. R. Sperr, Y. Majlesi, P. Valent, D. Kraft, and R. Valenta. 2001. Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination. FASEB J. 15: 2042-2044.
    • (2001) FASEB J. , vol.15 , pp. 2042-2044
    • Focke, M.1    Mahler, V.2    Ball, T.3    Sperr, W.R.4    Majlesi, Y.5    Valent, P.6    Kraft, D.7    Valenta, R.8
  • 26
    • 0014949207 scopus 로고
    • Cleavage of structural proteins during the assembly of the head of bacteriophage T4
    • Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
    • (1970) Nature , vol.227 , pp. 680-685
    • Laemmli, U.K.1
  • 27
    • 23244456566 scopus 로고    scopus 로고
    • Intranasal tolerance induction with polypeptides derived from 3 noncross-reactive major aeroallergens prevents allergic polysensitization in mice
    • Hufnagl, K., B. Winkler, M. Focke, R. Valenta, O. Scheiner, H. Renz, and U. Wiedermann. 2005. Intranasal tolerance induction with polypeptides derived from 3 noncross-reactive major aeroallergens prevents allergic polysensitization in mice. J. Allergy Clin. Immunol. 116: 370-376.
    • (2005) J. Allergy Clin. Immunol. , vol.116 , pp. 370-376
    • Hufnagl, K.1    Winkler, B.2    Focke, M.3    Valenta, R.4    Scheiner, O.5    Renz, H.6    Wiedermann, U.7
  • 29
    • 1042275745 scopus 로고    scopus 로고
    • Circular dichroism analysis of allergens
    • Verdino, P., and W. Keller. 2004. Circular dichroism analysis of allergens. Methods 32: 241-248.
    • (2004) Methods , vol.32 , pp. 241-248
    • Verdino, P.1    Keller, W.2
  • 30
    • 84892707552 scopus 로고    scopus 로고
    • Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy
    • Linhart, B., M. Narayanan, M. Focke-Tejkl, F. Wrba, S. Vrtala, and R. Valenta. 2014. Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy. Clin. Exp. Allergy 44: 278-287.
    • (2014) Clin. Exp. Allergy , vol.44 , pp. 278-287
    • Linhart, B.1    Narayanan, M.2    Focke-Tejkl, M.3    Wrba, F.4    Vrtala, S.5    Valenta, R.6
  • 31
    • 79955549894 scopus 로고    scopus 로고
    • Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1
    • Gieras, A., P. Cejka, K. Blatt, M. Focke-Tejkl, B. Linhart, S. Flicker, A. Stoecklinger, K. Marth, A. Drescher, J. Thalhamer, et al. 2011. Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1. J. Immunol. 186: 5333-5344.
    • (2011) J. Immunol. , vol.186 , pp. 5333-5344
    • Gieras, A.1    Cejka, P.2    Blatt, K.3    Focke-Tejkl, M.4    Linhart, B.5    Flicker, S.6    Stoecklinger, A.7    Marth, K.8    Drescher, A.9    Thalhamer, J.10
  • 32
    • 15444353066 scopus 로고    scopus 로고
    • Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation
    • Vrtala, S., T. Ball, S. Spitzauer, B. Pandjaitan, C. Suphioglu, B. Knox,W. R. Sperr, P. Valent, D. Kraft, and R. Valenta. 1998. Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation. J. Immunol. 160: 6137-6144.
    • (1998) J. Immunol. , vol.160 , pp. 6137-6144
    • Vrtala, S.1    Ball, T.2    Spitzauer, S.3    Pandjaitan, B.4    Suphioglu, C.5    Knox, B.6    Sperr, W.R.7    Valent, P.8    Kraft, D.9    Valenta, R.10
  • 35
    • 33749016485 scopus 로고    scopus 로고
    • Immunological mechanisms of allergen-specific immunotherapy
    • Larché, M., C. A. Akdis, and R. Valenta. 2006. Immunological mechanisms of allergen-specific immunotherapy. Nat. Rev. Immunol. 6: 761-771.
    • (2006) Nat. Rev. Immunol. , vol.6 , pp. 761-771
    • Larché, M.1    Akdis, C.A.2    Valenta, R.3
  • 36
    • 0036182689 scopus 로고    scopus 로고
    • Evolution of IgM, IgE and IgG1-4 antibody responses in early childhood monitored with recombinant allergen components: Implications for class switch mechanisms
    • Niederberger, V., B. Niggemann, D. Kraft, S. Spitzauer, and R. Valenta. 2002. Evolution of IgM, IgE and IgG1-4 antibody responses in early childhood monitored with recombinant allergen components: implications for class switch mechanisms. Eur. J. Immunol. 32: 576-584.
    • (2002) Eur. J. Immunol. , vol.32 , pp. 576-584
    • Niederberger, V.1    Niggemann, B.2    Kraft, D.3    Spitzauer, S.4    Valenta, R.5
  • 37
    • 84897115704 scopus 로고    scopus 로고
    • The production and regulation of IgE by the immune system
    • Wu, L. C., and A. A. Zarrin. 2014. The production and regulation of IgE by the immune system. Nat. Rev. Immunol. 14: 247-259.
    • (2014) Nat. Rev. Immunol. , vol.14 , pp. 247-259
    • Wu, L.C.1    Zarrin, A.A.2
  • 39
    • 84862777789 scopus 로고    scopus 로고
    • Fluorescent in vivo detection reveals that IgE+ B cells are restrained by an intrinsic cell fate predisposition
    • Yang, Z., B. M. Sullivan, and C. D. Allen. 2012. Fluorescent in vivo detection reveals that IgE+ B cells are restrained by an intrinsic cell fate predisposition. Immunity 36: 857-872.
    • (2012) Immunity , vol.36 , pp. 857-872
    • Yang, Z.1    Sullivan, B.M.2    Allen, C.D.3
  • 40
    • 0032033127 scopus 로고    scopus 로고
    • Humoral immunity due to long-lived plasma cells
    • Slifka, M. K., R. Antia, J. K. Whitmire, and R. Ahmed. 1998. Humoral immunity due to long-lived plasma cells. Immunity 8: 363-372.
    • (1998) Immunity , vol.8 , pp. 363-372
    • Slifka, M.K.1    Antia, R.2    Whitmire, J.K.3    Ahmed, R.4
  • 42
    • 78649828969 scopus 로고    scopus 로고
    • Nasal application of rBet v 1 or non-IgE-reactive T-cell epitope-containing rBet v 1 fragments has different effects on systemic allergen-specific antibody responses
    • Egger, C., F. Horak, S. Vrtala, R. Valenta, and V. Niederberger. 2010. Nasal application of rBet v 1 or non-IgE-reactive T-cell epitope-containing rBet v 1 fragments has different effects on systemic allergen-specific antibody responses. J. Allergy Clin. Immunol. 126: 1312-1315.e4.
    • (2010) J. Allergy Clin. Immunol. , vol.126 , pp. 1312-1312e4
    • Egger, C.1    Horak, F.2    Vrtala, S.3    Valenta, R.4    Niederberger, V.5
  • 46
    • 21844457947 scopus 로고    scopus 로고
    • Development of an in vitro system for the study of allergens and allergen-specific immunoglobulin e and immunoglobulin G: Fc? Receptor i supercross-linking is a possible new mechanism of immunoglobulin G-dependent enhancement of type i allergic reactions
    • Sellge, G., S. Laffer, C. Mierke, S. Vrtala, M. W. Hoffmann, J. Klempnauer, M. P. Manns, R. Valenta, and S. C. Bischoff. 2005. Development of an in vitro system for the study of allergens and allergen-specific immunoglobulin E and immunoglobulin G: Fc? receptor I supercross-linking is a possible new mechanism of immunoglobulin G-dependent enhancement of type I allergic reactions. Clin. Exp. Allergy 35: 774-781.
    • (2005) Clin. Exp. Allergy , vol.35 , pp. 774-781
    • Sellge, G.1    Laffer, S.2    Mierke, C.3    Vrtala, S.4    Hoffmann, M.W.5    Klempnauer, J.6    Manns, M.P.7    Valenta, R.8    Bischoff, S.C.9
  • 47
    • 76349094087 scopus 로고    scopus 로고
    • Developments in allergen-specific immunotherapy: From allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin e and T cell reactivity
    • Focke, M., I. Swoboda, K. Marth, and R. Valenta. 2010. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity. Clin. Exp. Allergy 40: 385-397.
    • (2010) Clin. Exp. Allergy , vol.40 , pp. 385-397
    • Focke, M.1    Swoboda, I.2    Marth, K.3    Valenta, R.4
  • 50
    • 84994908970 scopus 로고    scopus 로고
    • Development of an allergy immunotherapy leads to a new type of hepatitis B vaccine
    • Gerlich, W.H., and D. Glebe. 2016. Development of an allergy immunotherapy leads to a new type of hepatitis B vaccine. EBioMedicine 11: 5-6.
    • (2016) EBioMedicine , vol.11 , pp. 5-6
    • Gerlich, W.H.1    Glebe, D.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.